Procter & Gamble Hygiene & Healthcare Ltd. - Research Center
500459 PGHH Group (A) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Dec ' 20 | Jun ' 20 | Dec ' 19 | Dec ' 18 | Jun ' 18 | |
|---|---|---|---|---|---|
| Sales | 2,027.89 | 1,290.58 | 1,711.41 | 1,609.87 | 1,093.54 |
| Operating profit | 680.71 | 234.84 | 368.87 | 400.79 | 217.71 |
| Interest | 2.43 | 3.47 | 2.60 | 0.90 | 4.44 |
| Gross profit | 697.19 | 255.44 | 386.31 | 435.11 | 226.71 |
| EPS (Rs) | 155.42 | 49.39 | 84.03 | 82.63 | 39.37 |
Half yearly
results in details
| Dec ' 20 | Jun ' 20 | Dec ' 19 | Dec ' 18 | Jun ' 18 | |
|---|---|---|---|---|---|
| Other income | 18.91 | 24.07 | 20.04 | 35.22 | 13.44 |
| Stock adjustment | 13.99 | -20.40 | 12.58 | -38.13 | 9.17 |
| Raw material | 626.01 | 442.18 | 624.03 | 473.00 | 248.31 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 102.84 | 88.30 | 84.99 | 72.73 | 57.04 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | 198.77 | 115.83 | 212.47 | 172.88 | 140.28 |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 405.57 | 415.95 | 408.47 | 528.60 | 421.03 |
| Provisions made | - | 13.88 | - | - | - |
| Depreciation | 23.78 | 24.95 | 22.93 | 24.41 | 26.01 |
| Taxation | 168.93 | 70.18 | 90.61 | 142.47 | 72.91 |
| Net profit / loss | 504.48 | 160.31 | 272.77 | 268.23 | 127.79 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 32.46 | 32.46 | 32.46 | 32.46 | 32.46 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 33.57 | 18.20 | 21.55 | 24.90 | 19.91 |
| GPM (%) | 34.06 | 19.43 | 22.31 | 26.45 | 20.48 |
| NPM (%) | 24.65 | 12.19 | 15.75 | 16.30 | 11.54 |
© 2021 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis